Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology
|
October 1, 1987
Effects of nortriptyline and its 10-hydroxy metabolite on plasma noradrenaline (NA) concentrations, heart rate and blood pressure during intravenous NA infusion
C Nordin, P Collste, K Otani, et al.
European Journal of Clinical Pharmacology
|
February 6, 1976
Interindividual differences in chlorthalidone concentration in plasma and red cells of man after single and multiple doses
P Collste, M Garle, M D Rawlins, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1973
Quantitative determination of carbamazepine in plasma by mass fragmentography
L Palmér, L Bertilsson, P Collste, et al.
European Journal of Clinical Pharmacology
|
August 23, 1974
Gas chromatographic assessment of the reproducibility of phenazone plasma half-life in young healthy volunteers
S Lindgren, P Collste, B Norlander, et al.
European Journal of Clinical Pharmacology
|
February 28, 1975
Distribution and elimination kinetics of carbamazepine in man
M D Rawlins, P Collste, L Bertilsson, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
September 1, 1987
Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients
B Edgar, P Collste, K Haglund, et al.
Drugs
|
January 1, 1987
Pharmacokinetics and haemodynamics of felodipine as monotherapy in hypertensive patients
B Edgar, P Collste, K Haglund, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1979
Contribution of 4-hydroxy-alprenolol to adrenergic beta receptor blockade of alprenolol
P Collste, K O Borg, H Aström, et al.
Lakartidningen
|
June 12, 1972
[Arrhythmia prophylaxis with procanamide: inadequate dosage?]
P Collste, E Karlsson, B Norlander, et al.
European Journal of Clinical Pharmacology
|
June 15, 1976
Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade
P Collste, K Haglund, M Frisk-Holmberg, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Methods and Findings in Experimental and Clinical Pharmacology
|
October 1, 1987
Effects of nortriptyline and its 10-hydroxy metabolite on plasma noradrenaline (NA) concentrations, heart rate and blood pressure during intravenous NA infusion
C Nordin, P Collste, K Otani, et al.
European Journal of Clinical Pharmacology
|
February 6, 1976
Interindividual differences in chlorthalidone concentration in plasma and red cells of man after single and multiple doses
P Collste, M Garle, M D Rawlins, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1973
Quantitative determination of carbamazepine in plasma by mass fragmentography
L Palmér, L Bertilsson, P Collste, et al.
European Journal of Clinical Pharmacology
|
August 23, 1974
Gas chromatographic assessment of the reproducibility of phenazone plasma half-life in young healthy volunteers
S Lindgren, P Collste, B Norlander, et al.
European Journal of Clinical Pharmacology
|
February 28, 1975
Distribution and elimination kinetics of carbamazepine in man
M D Rawlins, P Collste, L Bertilsson, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
September 1, 1987
Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients
B Edgar, P Collste, K Haglund, et al.
Drugs
|
January 1, 1987
Pharmacokinetics and haemodynamics of felodipine as monotherapy in hypertensive patients
B Edgar, P Collste, K Haglund, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1979
Contribution of 4-hydroxy-alprenolol to adrenergic beta receptor blockade of alprenolol
P Collste, K O Borg, H Aström, et al.
Lakartidningen
|
June 12, 1972
[Arrhythmia prophylaxis with procanamide: inadequate dosage?]
P Collste, E Karlsson, B Norlander, et al.
European Journal of Clinical Pharmacology
|
June 15, 1976
Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade
P Collste, K Haglund, M Frisk-Holmberg, et al.
Page
of 4